Retaglutide is a novel GLP-1 receptor agonist currently under investigation for the management of type 2 diabetes. This drug works by mimicking the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://dawudkthw629587.blogspothub.com/37861895/retaglutide-a-promising-glp-1-receptor-agonist